Novavax, Inc. (NVAX) - NASDAQ
  • Alexander Valtsev | Send Message 14 Jul

    Can Novavax Regain Its Former Glory? Learn more: http://bit.ly/140716NVAX $NVAX
    Reply
      • Alexander Valtsev | Send Message 24 Jun

        Brexit Bargains: 3 Clinical-Stage Biotechs to Buy: http://bit.ly/240616NVAX $NVAX $KITE $FXLN
        Reply
          • Stock Social | Send Message 21 Jun

            Market Morning Sentiment: $NVAX $SPY, $NVAX, $AZN http://seekingalpha.com/p/2wv2t
            Reply
              • timtrading | Send Message 14 Jun

                bullish candlestick patterns $GE,$MRK,$HST,$COP,$GPS,$NVAX,$ZTS,$LLY,$BRK.B,$NFX http://bit.ly/1aT1pSL
                Reply
                  • terrymcnutt | Send Message 14 Jun

                    $NVAX
                    Reply
                      • Colin Macleod | Send Message 14 Jun

                        Bullish engulfing candles to watch for breakouts http://bit.ly/1XnZ0F4 $GE $MRK $HST $FLEX $GPS $NVAX $SONC
                        Reply
                          • Alexander Valtsev | Send Message 14 Jun

                            Here's Why Novavax's Stock Could Double: http://bit.ly/140616NVAX $NVAX
                            Reply
                              • Will Driscoll | Send Message 10 Jun

                                Novavax: Profits Finally In View $NVAX http://seekingalpha.com/a/2dc0i
                                Reply
                                  • LSS Trading | Send Message 25 May

                                    Novavax Inc. $NVAX - Resistance Breakout. Target $6.50 http://tinyurl.com/zmop9na
                                    Reply
                                      • LSS Trading | Send Message 25 May

                                        Novavax Inc. $NVAX - Resistance $5.60 http://tinyurl.com/hqn5r5s
                                        Reply
                                          Company Description
                                          Novavax, Inc. operates as a clinical-stage biopharmaceutical company, which engages in development of novel recombinant vaccines to address a broad range of infectious diseases. The company's technology platform is based on proprietary recombinant vaccine technology that includes virus-like... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States